{"url_path":"/sec/arqt/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1787306/0001628280-26-048469-index.html","accession_number":"0001628280-26-048469","cik":"0001787306","ticker":"ARQT","issuer_name":"Arcutis Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1787306/0001628280-26-048469-index.html","primary_entity_key":"0001787306","primary_entity_name":"Arcutis Biotherapeutics, Inc."},"word_count":80,"has_tables":true,"body_markdown":"Item 9.01Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\nDescription\n\n[99.1](exhibit991bodappointment.htm)\n\n[Arcutis Biotherapeutics Inc. Appoints](exhibit991bodappointment.htm)[Chr](exhibit991bodappointment.htm)[is](exhibit991bodappointment.htm)[t](exhibit991bodappointment.htm)[opher](exhibit991bodappointment.htm)[Peetz t](exhibit991bodappointment.htm)[o Board of Directors.](exhibit991bodappointment.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nARCUTIS BIOTHERAPEUTICS, INC.\n\nDate: July 16, 2026\nBy:\n/s/ Latha Vairavan\n\nLatha Vairavan\n\nChief Financial Officer"}